Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil–CNPs) against SARS-CoV-2 ( in silico and in vitro study)

Authors:

Abstract
To develop a specific treatment against COVID-19, we investigated silymarin–chitosan nanoparticles (Sil–CNPs) as an antiviral agent against SARS-CoV-2 using in silico and in vitro approaches.
Funding Information
  • Academy of Scientific Research and Technology

This publication has 42 references indexed in Scilit: